432 related articles for article (PubMed ID: 31261951)
1. Chronic Pruritus Responding to Dupilumab-A Case Series.
Zhai LL; Savage KT; Qiu CC; Jin A; Valdes-Rodriguez R; Mollanazar NK
Medicines (Basel); 2019 Jun; 6(3):. PubMed ID: 31261951
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of dupilumab in chronic prurigo and chronic idiopathic pruritus: a systematic review of current evidence and analysis of response predictors.
Gael M; Adam T; Mariano-Bourin M; Bursztejn AC
J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):1541-1551. PubMed ID: 35569006
[TBL] [Abstract][Full Text] [Related]
3. Dupilumab in prurigo nodularis: a systematic review of current evidence and analysis of predictive factors to response.
Husein-ElAhmed H; Steinhoff M
J Dermatolog Treat; 2022 May; 33(3):1547-1553. PubMed ID: 33200955
[TBL] [Abstract][Full Text] [Related]
4. Dupilumab use in dermatologic conditions beyond atopic dermatitis - a systematic review.
Hendricks AJ; Yosipovitch G; Shi VY
J Dermatolog Treat; 2021 Feb; 32(1):19-28. PubMed ID: 31693426
[No Abstract] [Full Text] [Related]
5. Resolution of Treatment-Refractory Prurigo Nodularis With Dupilumab: A Case Series.
Wieser JK; Mercurio MG; Somers K
Cureus; 2020 Jun; 12(6):e8737. PubMed ID: 32714676
[TBL] [Abstract][Full Text] [Related]
6. Recalcitrant prurigo nodularis treated successfully with dupilumab.
Rambhia PH; Levitt JO
JAAD Case Rep; 2019 May; 5(5):471-473. PubMed ID: 31192991
[No Abstract] [Full Text] [Related]
7. A critical review of dupilumab for adult patients with prurigo nodularis.
Biazus Soares G; Yosipovitch G
Expert Rev Clin Immunol; 2024 Mar; 20(3):249-254. PubMed ID: 37811660
[TBL] [Abstract][Full Text] [Related]
8. Dupilumab and prurigo nodularis-like phenotype in atopic dermatitis: our experience of efficacy.
Ferrucci S; Tavecchio S; Berti E; Angileri L
J Dermatolog Treat; 2021 Jun; 32(4):453-454. PubMed ID: 31442084
[TBL] [Abstract][Full Text] [Related]
9. Dupilumab for prurigo nodularis: Case series and review of the literature.
Holm JG; Agner T; Sand C; Thomsen SF
Dermatol Ther; 2020 Mar; 33(2):e13222. PubMed ID: 31917498
[TBL] [Abstract][Full Text] [Related]
10. Dupilumab for pediatric prurigo nodularis: A case report.
Fachler T; Maria Faitataziadou S; Molho-Pessach V
Pediatr Dermatol; 2021 Jan; 38(1):334-335. PubMed ID: 33247435
[TBL] [Abstract][Full Text] [Related]
11. Treatment of patients with chronic pruritus of unknown origin with dupilumab.
Jeon J; Wang F; Badic A; Kim BS
J Dermatolog Treat; 2022 May; 33(3):1754-1757. PubMed ID: 33557654
[TBL] [Abstract][Full Text] [Related]
12. Dupilumab for cancer-associated refractory pruritus.
Talmon A; Elias S; Rubin L; Ribak Y; Ben Dori E; Shamriz O; Lotem M; Adini I; Tal Y
J Allergy Clin Immunol Glob; 2023 Aug; 2(3):100128. PubMed ID: 37779518
[TBL] [Abstract][Full Text] [Related]
13. Dupilumab for bullous pemphigoid with intractable pruritus.
Seidman JS; Eichenfield DZ; Orme CM
Dermatol Online J; 2019 Nov; 25(11):. PubMed ID: 32045153
[TBL] [Abstract][Full Text] [Related]
14. Dupilumab for the Treatment of Prurigo Nodularis.
Alkhaleefa A; Woo TE; Parsons L
Skin Therapy Lett; 2023 Nov; 28(6):7-9. PubMed ID: 38016088
[TBL] [Abstract][Full Text] [Related]
15. Dupilumab for the treatment of prurigo nodularis: A systematic review.
Cao P; Xu W; Jiang S; Zhang L
Front Immunol; 2023; 14():1092685. PubMed ID: 36742321
[TBL] [Abstract][Full Text] [Related]
16. Dupilumab in Dermatology: Potential for Uses Beyond Atopic Dermatitis.
Maloney NJ; Tegtmeyer K; Zhao J; Worswick S
J Drugs Dermatol; 2019 Oct; 18(10):. PubMed ID: 31603635
[TBL] [Abstract][Full Text] [Related]
17. A real-world observational study of dupilumab treatment in adult patients with prurigo nodularis.
Zhang Z; Li S; Wang Y; Zhao J
An Bras Dermatol; 2023; 98(4):440-448. PubMed ID: 36966024
[TBL] [Abstract][Full Text] [Related]
18. Dupilumab: A review of its use in the treatment of atopic dermatitis.
Gooderham MJ; Hong HC; Eshtiaghi P; Papp KA
J Am Acad Dermatol; 2018 Mar; 78(3 Suppl 1):S28-S36. PubMed ID: 29471919
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of Dupilumab for Chronic Prurigo in Chinese Patients: A Real-World Case Series Study.
Wei L; Yin M; Yang X; Chen J; Wu R; Yang H; Dou X
Clin Drug Investig; 2023 Oct; 43(10):799-805. PubMed ID: 37717240
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of dupilumab in prurigo nodularis in elderly patient.
Giura MT; Viola R; Fierro MT; Ribero S; Ortoncelli M
Dermatol Ther; 2020 Jan; 33(1):e13201. PubMed ID: 31856368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
